Skip to main content
SpringerLink
Log in

Resistant Hypertension: Epidemiological and Evolving Therapeutic Concepts

  • Chapter
  • First Online:
Special Issues in Hypertension

  • 1288 Accesses

Abstract

Resistant hypertension is a clinical condition characterized by the inability of antihypertensive treatment to achieve blood pressure control. The main features of this condition are its complex pathophysiological background, its not infrequent occurrence in clinical practice, and the difficulty in implementing an adequate therapeutic approach. This chapter, after briefly recalling the main epidemiological, pathophysiological, and clinical features of the disease, focuses on the pharmacological and nonpharmacological interventions, with special emphasis on carotid baroreceptor stimulation and the renal denervation procedure. The pros and cons of each of these interventions are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mancia G, De Backer G, Dominiczak A et al (2007) Management of arterial hypertension of the European Society of Hypertension; European Society of Cardiology 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25:1105–1187

    Google Scholar 

  2. Mancia G, Laurent S, Agabiti-Rosei E et al (2009) European Society of Hypertension reappraisal of European guidelines on hypertension management: a European Society of Hypertension task force document. J Hypertens 27:2121–2158

    Google Scholar 

  3. Egan BM, Zhao Y, Axon RN (2010) US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA 303:2043–2050

    Article  PubMed  CAS  Google Scholar 

  4. Egan BM, Zhao Y, Axon RN et al (2011) Uncontrolled and apparent treatment resistant hypertension in the United States, 1988–2008. Circulation 124:1046–1058

    Article  PubMed  Google Scholar 

  5. Grassi G, Cifkova R, Laurent S et al (2011) Blood pressure control and cardiovascular risk profile in hypertensive patients from central and eastern European countries: results of the BP-CARE study. Eur Heart J 32:218–225

    Article  PubMed  Google Scholar 

  6. EUROASPIRE Study Group. European action on secondary prevention through intervention to reduce events (1997) EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. Eur Heart J 18:1569–1582

    Article  Google Scholar 

  7. EUROASPIRE, II Study Group (2001) Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J 22:554–572

    Article  Google Scholar 

  8. Kotseva K, Wood D,De Backer G et al EUROASPIRE study group (2009) EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil 16:121–137

    Google Scholar 

  9. Sarafidis PA (2011) Epidemiology of resistant hypertension. J Clin Hypertens 13:523–528

    Article  Google Scholar 

  10. Seravalle G, Volpe M, Ganz F et al (2011) Sympathetic nerve traffic, insulin resistance and baroreflex control of circulation in patients with resistant hypertension. Eur Heart J 32:S500 (ABSTRACT)

    Google Scholar 

  11. Calhoun DA, Jones D, Textor S et al ;American Heart Association Professional Education Committee (2008) Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 117:e510–e526

    Google Scholar 

  12. Persell SD (2011) Prevalence of resistant hypertension in the United States, 2003–2008. Hypertension 57:1076–1080

    Article  PubMed  CAS  Google Scholar 

  13. Acelajado MC, Pisoni R, Dudenbostel T et al (2012) Refractory hypertension: definition, prevalence, and patient characteristics. J Clin Hypertens 14:7–12

    Article  Google Scholar 

  14. Brambilla G, Seravalle G, Cifkova R et al (2012) Prevalence and main features of resistant hypertension in central and Eastern Europe: data from the BP-CARE Study. J Hypertens (in press. abstract)

    Google Scholar 

  15. Bombelli M, Facchetti R, Brambilla G et al (2012) Clinic, home, 24-hour blood pressure profiles and clinical correlates in resistant hypertension: data form the PAMELA Study. J Hypertens (in press. abstract)

    Google Scholar 

  16. Salles GF, Cardoso CR, Muxfeldt ES (2008) Prognostic influence of office and ambulatory blood pressures in resistant hypertension. Arch Intern Med 168:2340–2346

    Article  PubMed  Google Scholar 

  17. Zannad F (2007) Aldosterone antagonist therapy in resistant hypertension. J Hypertens 25:742–750

    Article  Google Scholar 

  18. Weber MA, Black H, Bakris G et al (2009) A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial. Lancet 374:1423–1431

    Article  PubMed  CAS  Google Scholar 

  19. Grassi G (2009) Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives. Hypertension 54:690–697

    Article  PubMed  CAS  Google Scholar 

  20. Lohmeier TE, Iliescu R (2011) Chronic lowering of blood pressure by carotid baroreflex activation: mechanisms and potential for hypertension therapy. Hypertension 57:880–886

    Article  PubMed  CAS  Google Scholar 

  21. Scheffers IJ, Kroon AA, Schmidli J et al (2010) Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study. J Am Coll Cardiol 56:1254–1258

    Article  PubMed  Google Scholar 

  22. Bisognano JD, Bakris G, Nadim MK et al (2011) Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled Rheos pivotal trial. J Am Coll Cardiol 58:765–773

    Article  PubMed  Google Scholar 

  23. Krum H, Sobotka P, Mahfoud F et al (2011) Device-based antihypertensive therapy: therapeutic modulation of the autonomic nervous system. Circulation 2011:209–215

    Article  Google Scholar 

  24. Krum H, Schlaich M, Whitbourn R et al (2009) Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373:1275–1281

    Article  PubMed  Google Scholar 

  25. Esler MD, Krum H, Sobotka PA et al (2010) Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 376:1903–1909

    Article  PubMed  Google Scholar 

  26. Symplicity HTN-1 Investigators (2011) Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension 57:911–917

    Google Scholar 

  27. Schlaich MP, Sobotka PA, Krum H et al (2009) Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 361:932–934

    Article  PubMed  CAS  Google Scholar 

  28. Mahfoud F, Schlaich M, Kindermann I et al (2011) Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study. Circulation 123:1940–1946

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinica Medica, Ospedale S. Gerardo, Monza, Italy

    Guido Grassi

Authors
  1. Guido Grassi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Guido Grassi .

Editor information

Editors and Affiliations

  1. , Internal Medicine, American University of Beirut Medical Ce, Riad El Solh, Beirut, 1107-2020, Lebanon

    Adel E. Berbari

  2. Clinica Medica, Ospedale S. Gerardo, Università di Milano-Bicocca, V .Donizetti 106, Milano, Monza, 20133, Italy

    Giuseppe Mancia

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Italia

About this chapter

Cite this chapter

Grassi, G. (2012). Resistant Hypertension: Epidemiological and Evolving Therapeutic Concepts. In: Berbari, A., Mancia, G. (eds) Special Issues in Hypertension. Springer, Milano. https://doi.org/10.1007/978-88-470-2601-8_3

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2601-8_3

  • Published:

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-2600-1

  • Online ISBN: 978-88-470-2601-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation